Business Context and Reporting Period
This Form 8-K is a Current Report filed by Bond Laboratories, Inc. (noted as FITLIFE BRANDS, INC. in metadata) on August 20, 2009. The filing reports a corporate governance change involving the appointment of an Interim Chief Financial Officer and the engagement of a financial strategy consultant.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and consulting arrangements rather than financial performance data.
Material Changes
- Consulting Engagement: Effective August 20, 2009, the Company engaged Burnham Hill Advisors LLC (BHA) to serve as its financial and corporate strategy consultant.
- Executive Appointment: Michael Abrams, an affiliate of BHA and Managing Director of Burnham Hill Partners LLC, was appointed as the Company's Interim Chief Financial Officer (Principal Accounting Officer).
- Background: Mr. Abrams holds an MBA with Honors from the University of Chicago Booth School of Business and has extensive experience advising public companies.
Guidance, Outlook, and Risks
The filing includes a standard cautionary note regarding forward-looking statements. Management disclaims any duty to update these statements and warns that actual results may differ materially from projections due to inherent uncertainties in estimates regarding orders, sales, operating margins, and cash flow. No specific financial guidance or outlook was provided in this document.
Investor Verification Checklist
- Verify the terms of the consulting agreement between Bond Laboratories, Inc. and Burnham Hill Advisors LLC (Exhibit 99.1).
- Confirm the duration and compensation structure for Michael Abrams' role as Interim CFO.
- Review subsequent filings (10-K or 10-Q) for the first financial statements prepared under the new CFO's oversight.
- Check for any related party transaction disclosures regarding the engagement of BHA.